3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
19
Prostatic Neoplasms
18
Glioma
13
Neoplasm Metastasis
12
Carcinoma, Non-Small-Cell Lung
12
Urinary Bladder Neoplasms
11
Pancreatic Neoplasms
11
Multiple Myeloma
11
Breast Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
9
Mouth Neoplasms
9
Lymphoma
9
Carcinoma, Renal Cell
9
Melanoma
8
Glioblastoma
8
Colorectal Neoplasms
8
Ovarian Neoplasms
7
Oropharyngeal Neoplasms
7
Laryngeal Neoplasms
7
Carcinoma, Transitional Cell
7
Carcinoma, Hepatocellular
7
Carcinoma
7
Wilms Tumor
6
Triple Negative Breast Neoplasms
6
Neuroblastoma
6
Nasopharyngeal Carcinoma
6
Medulloblastoma
6
Fallopian Tube Neoplasms
6
Endometrial Neoplasms
6
Thyroid Neoplasms
5
Interventions
selpercatinib
1
fludarabine
1
aldesleukin
1
Nivolumab
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Carcinoma, Anaplastic
×
Magnetic Resonance Spectroscopy
×
30 days
×
Clear all
No trials found.